The University of Chicago Header Logo

Connection

Ardaman Shergill to Trifluridine

Back to Details
This is a "connection" page, showing publications Ardaman Shergill has written about Trifluridine.
Ardaman Shergill
Connection Strength
0.056
Trifluridine
  1. Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study. Lancet. 2023 07 01; 402(10395):41-53.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.